Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 Before After Body Composition: Clinical vs. Anecdotal Comparison

Lean Mass Gain 2–4 kg (DEXA-verified) 2.5–5 kg (self-reported) Clinical data more reliable. Anecdotal figures likely include water weight and glycogen Body Fat Reduction 1–3% (DEXA-verified) 2–5% (visual estimate) Visual estimates overstate fat loss. Lighting,

This comparison does not assign a generated winner or score.

  • Lean Mass Gain
  • 2–4 kg (DEXA-verified)
  • 2.5–5 kg (self-reported)
  • Clinical data more reliable. Anecdotal figures likely include water weight and glycogen
  • Body Fat Reduction
  • 1–3% (DEXA-verified)
  • 2–5% (visual estimate)
  • Visual estimates overstate fat loss. Lighting, posing, and dehydration skew perception
  • Typical Dose
  • 20–25 mg daily
  • 20–30 mg daily
  • Clinical range is safer. Doses above 25 mg increase side effects without proportional benefit
  • Training Frequency
  • 3–4 sessions/week
  • 5–6 sessions/week
  • Higher frequency in anecdotal reports explains some of the discrepancy in results
  • Diet Structure
  • Controlled caloric deficit
  • Variable (often unreported)
  • Clinical trials use structured nutrition. Anecdotal results conflate compound effects with dietary changes
  • Time to Visible Change
  • 8–10 weeks
  • 6–8 weeks (subjective)
  • Anecdotal timelines reflect water retention and muscle fullness, not true lean tissue accrual
  • MK-677's body composition effects are real but modest. The compound creates a favorable hormonal environment for recomposition, but it doesn't override poor training or inconsistent nutrition. Clinical data provides the floor; anecdotal reports represent the ceiling under optimal conditions.
More references

Related material